Structure Therapeutics — Obesity company profile
Structure Therapeutics (GPCR) in obesity: aleniglipron (oral GLP-1). Investment thesis, pipeline, catalysts, score and risks — sourced on ObesityIntel.
Structure Therapeutics (GPCR) in obesity: aleniglipron (oral GLP-1). Investment thesis, pipeline, catalysts, score and risks — sourced on ObesityIntel.